Specialist endocrine assessment of polycystic ovary syndrome (PCOS), hormonal imbalance, insulin resistance, and metabolic complications. Compassionate, evidence-based care from Dr Kazmi, Consultant Endocrinologist.
Polycystic ovary syndrome (PCOS) is one of the most common hormonal disorders affecting women of reproductive age, estimated to affect 8–13% of women. It is characterised by a combination of hormonal imbalance (elevated androgens), ovulatory dysfunction, and polycystic ovarian morphology on ultrasound.
PCOS is a heterogeneous condition — not every patient has all features, and the clinical presentation varies widely. It has significant metabolic implications, with high rates of insulin resistance, Type 2 diabetes risk, and cardiovascular risk factors. The psychological burden — including anxiety, depression, and effects on body image — is also important and often underaddressed.
It is worth noting that polycystic ovarian morphology (PCOM or PMOS) — the appearance of multiple small follicles on ultrasound — can occur in women without the full syndrome and does not alone establish a PCOS diagnosis.
Symptoms vary significantly between individuals. Some women with PCOS are lean with normal periods but have elevated androgens; others have significant metabolic features. Specialist assessment allows precise characterisation of the phenotype.
Dr Kazmi provides a thorough endocrinological assessment of PCOS, addressing hormonal, metabolic, and clinical aspects of the condition and providing a structured management plan.
Comprehensive hormonal assessment including LH, FSH, total and free testosterone, DHEAS, SHBG, AMH, and exclusion of other androgen excess disorders such as congenital adrenal hyperplasia and androgen-secreting tumours.
Fasting glucose, insulin, HbA1c, and lipid profile. Identification and management of metabolic syndrome features — a key component of long-term health in PCOS.
Assessment and management of oligo/amenorrhoea, including medical treatment to regulate cycles and monitoring for endometrial health implications of prolonged anovulation.
Evaluation and treatment of excess hair growth and androgen-related features, with medical management options discussed alongside cosmetic approaches.
Assessment of ovulatory dysfunction affecting fertility. Coordination with reproductive medicine where ovulation induction or further fertility assessment is indicated.
Proactive monitoring and management of long-term PCOS-associated risks including Type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease.
PCOS is diagnosed using the Rotterdam criteria (2003), which require two out of three features: oligo- or anovulation, clinical or biochemical signs of hyperandrogenism, and polycystic ovarian morphology on ultrasound — after exclusion of other conditions such as thyroid disease, hyperprolactinaemia, and congenital adrenal hyperplasia.
Management is tailored to the individual's presenting features and priorities. Lifestyle interventions (dietary modification, physical activity, and weight management where appropriate) remain fundamental. Medical management may address insulin resistance, menstrual regularity, androgen excess, and fertility depending on clinical needs.
All consultations are led by Dr Syed Kashif Hussain Kazmi, Consultant Endocrinologist (IMC: 213626), who provides a structured, evidence-based assessment in a sensitive and supportive environment.
Book a private consultation with Dr Kazmi, Consultant Endocrinologist, for a comprehensive assessment of PCOS and hormonal health.